Logo image of DX

DYNEX CAPITAL INC (DX) Stock Fundamental Analysis

NYSE:DX - New York Stock Exchange, Inc. - US26817Q8868 - REIT - Currency: USD

12.2587  +0.04 (+0.32%)

Fundamental Rating

4

DX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 65 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. While DX is still in line with the averages on profitability rating, there are concerns on its financial health. DX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

DX had positive earnings in the past year.
In the past year DX had a positive cash flow from operations.
DX had positive earnings in 4 of the past 5 years.
DX had a positive operating cash flow in each of the past 5 years.
DX Yearly Net Income VS EBIT VS OCF VS FCFDX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

The Return On Assets of DX (0.70%) is better than 69.23% of its industry peers.
With a decent Return On Equity value of 4.51%, DX is doing good in the industry, outperforming 67.69% of the companies in the same industry.
Industry RankSector Rank
ROA 0.7%
ROE 4.51%
ROIC N/A
ROA(3y)1.61%
ROA(5y)2.5%
ROE(3y)7.47%
ROE(5y)11.89%
ROIC(3y)N/A
ROIC(5y)N/A
DX Yearly ROA, ROE, ROICDX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20

1.3 Margins

DX has a Profit Margin of 18.45%. This is amongst the best in the industry. DX outperforms 86.15% of its industry peers.
DX's Profit Margin has declined in the last couple of years.
DX's Gross Margin of 7.23% is on the low side compared to the rest of the industry. DX is outperformed by 89.23% of its industry peers.
DX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 18.45%
GM 7.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.42%
PM growth 5YN/A
GM growth 3Y-75.33%
GM growth 5Y-47.03%
DX Yearly Profit, Operating, Gross MarginsDX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K -4K

1

2. Health

2.1 Basic Checks

DX does not have a ROIC to compare to the WACC, probably because it is not profitable.
DX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DX has been increased compared to 5 years ago.
The debt/assets ratio for DX has been reduced compared to a year ago.
DX Yearly Shares OutstandingDX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DX Yearly Total Debt VS Total AssetsDX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

DX has an Altman-Z score of -0.91. This is a bad value and indicates that DX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DX (-0.91) is worse than 80.00% of its industry peers.
The Debt to FCF ratio of DX is 191.22, which is on the high side as it means it would take DX, 191.22 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DX (191.22) is worse than 61.54% of its industry peers.
A Debt/Equity ratio of 5.19 is on the high side and indicates that DX has dependencies on debt financing.
The Debt to Equity ratio of DX (5.19) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 5.19
Debt/FCF 191.22
Altman-Z -0.91
ROIC/WACCN/A
WACC6.32%
DX Yearly LT Debt VS Equity VS FCFDX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.05 indicates that DX may have some problems paying its short term obligations.
DX's Current ratio of 0.05 is on the low side compared to the rest of the industry. DX is outperformed by 81.54% of its industry peers.
DX has a Quick Ratio of 0.05. This is a bad value and indicates that DX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of DX (0.05) is worse than 81.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
DX Yearly Current Assets VS Current LiabilitesDX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 108.26% over the past year.
The earnings per share for DX have been decreasing by -18.72% on average. This is quite bad
The Revenue has grown by 73.74% in the past year. This is a very strong growth!
Measured over the past years, DX shows a quite strong growth in Revenue. The Revenue has been growing by 13.32% on average per year.
EPS 1Y (TTM)108.26%
EPS 3Y-18.72%
EPS 5YN/A
EPS Q2Q%170%
Revenue 1Y (TTM)73.74%
Revenue growth 3Y68.26%
Revenue growth 5Y13.32%
Sales Q2Q%636.75%

3.2 Future

DX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 73.39% yearly.
The Revenue is expected to grow by 197.50% on average over the next years. This is a very strong growth
EPS Next Y369.35%
EPS Next 2Y128.96%
EPS Next 3Y73.39%
EPS Next 5YN/A
Revenue Next Year617.4%
Revenue Next 2Y197.5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DX Yearly Revenue VS EstimatesDX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 100M 200M 300M
DX Yearly EPS VS EstimatesDX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 136.21, the valuation of DX can be described as expensive.
Based on the Price/Earnings ratio, DX is valued a bit more expensive than the industry average as 67.69% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Earnings ratio of 27.15, DX is valued quite expensively.
With a Price/Forward Earnings ratio of 9.00, the valuation of DX can be described as very reasonable.
Based on the Price/Forward Earnings ratio, DX is valued a bit cheaper than 63.08% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of DX to the average of the S&P500 Index (21.60), we can say DX is valued rather cheaply.
Industry RankSector Rank
PE 136.21
Fwd PE 9
DX Price Earnings VS Forward Price EarningsDX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of DX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 34.7
EV/EBITDA N/A
DX Per share dataDX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DX's earnings are expected to grow with 73.39% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y128.96%
EPS Next 3Y73.39%

5

5. Dividend

5.1 Amount

DX has a Yearly Dividend Yield of 16.72%, which is a nice return.
Compared to an average industry Dividend Yield of 11.56, DX pays a better dividend. On top of this DX pays more dividend than 93.85% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, DX pays a better dividend.
Industry RankSector Rank
Dividend Yield 16.72%

5.2 History

The dividend of DX decreases each year by -11.72%.
DX has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-11.72%
Div Incr Years0
Div Non Decr Years0
DX Yearly Dividends per shareDX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8

5.3 Sustainability

DX pays out 213.53% of its income as dividend. This is not a sustainable payout ratio.
DP213.53%
EPS Next 2Y128.96%
EPS Next 3Y73.39%
DX Yearly Income VS Free CF VS DividendDX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M
DX Dividend Payout.DX Dividend Payout, showing the Payout Ratio.DX Dividend Payout.PayoutRetained Earnings

DYNEX CAPITAL INC

NYSE:DX (7/1/2025, 12:37:09 PM)

12.2587

+0.04 (+0.32%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)04-21 2025-04-21/bmo
Earnings (Next)07-21 2025-07-21/bmo
Inst Owners48.98%
Inst Owner Change25.12%
Ins Owners1.05%
Ins Owner Change10.58%
Market Cap1.31B
Analysts84
Price Target13.69 (11.68%)
Short Float %4.62%
Short Ratio1.37
Dividend
Industry RankSector Rank
Dividend Yield 16.72%
Yearly Dividend1.67
Dividend Growth(5Y)-11.72%
DP213.53%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-23 2025-05-23 (0.17)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.77%
Min EPS beat(2)-13.24%
Max EPS beat(2)42.78%
EPS beat(4)2
Avg EPS beat(4)-44.47%
Min EPS beat(4)-246.74%
Max EPS beat(4)42.78%
EPS beat(8)2
Avg EPS beat(8)-206.21%
EPS beat(12)2
Avg EPS beat(12)-164.38%
EPS beat(16)4
Avg EPS beat(16)-122.86%
Revenue beat(2)0
Avg Revenue beat(2)-38.13%
Min Revenue beat(2)-51.61%
Max Revenue beat(2)-24.66%
Revenue beat(4)1
Avg Revenue beat(4)-4.57%
Min Revenue beat(4)-83.68%
Max Revenue beat(4)141.66%
Revenue beat(8)3
Avg Revenue beat(8)-101.71%
Revenue beat(12)5
Avg Revenue beat(12)-50.56%
Revenue beat(16)6
Avg Revenue beat(16)-38.27%
PT rev (1m)0%
PT rev (3m)-5.29%
EPS NQ rev (1m)-4.68%
EPS NQ rev (3m)35.77%
EPS NY rev (1m)7.5%
EPS NY rev (3m)21.7%
Revenue NQ rev (1m)-2.38%
Revenue NQ rev (3m)39.75%
Revenue NY rev (1m)-2.42%
Revenue NY rev (3m)22.29%
Valuation
Industry RankSector Rank
PE 136.21
Fwd PE 9
P/S 3.85
P/FCF 34.7
P/OCF 34.7
P/B 0.94
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)0.09
EY0.73%
EPS(NY)1.36
Fwd EY11.11%
FCF(TTM)0.35
FCFY2.88%
OCF(TTM)0.35
OCFY2.88%
SpS3.19
BVpS13.03
TBVpS13.03
PEG (NY)0.37
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.7%
ROE 4.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 18.45%
GM 7.23%
FCFM 11.08%
ROA(3y)1.61%
ROA(5y)2.5%
ROE(3y)7.47%
ROE(5y)11.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-37.42%
PM growth 5YN/A
GM growth 3Y-75.33%
GM growth 5Y-47.03%
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 5.19
Debt/FCF 191.22
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 60.08%
Current Ratio 0.05
Quick Ratio 0.05
Altman-Z -0.91
F-Score5
WACC6.32%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)108.26%
EPS 3Y-18.72%
EPS 5YN/A
EPS Q2Q%170%
EPS Next Y369.35%
EPS Next 2Y128.96%
EPS Next 3Y73.39%
EPS Next 5YN/A
Revenue 1Y (TTM)73.74%
Revenue growth 3Y68.26%
Revenue growth 5Y13.32%
Sales Q2Q%636.75%
Revenue Next Year617.4%
Revenue Next 2Y197.5%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y87.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.37%
FCF growth 3Y-53.91%
FCF growth 5Y-39.34%
OCF growth 1Y-60.37%
OCF growth 3Y-53.91%
OCF growth 5Y-39.34%